Takeda’s CEO under pressure & more — 5 GI company key notes

Here are five updates on GI companies from the past week:

Advertisement

Innovate Biopharmaceuticals agreed to acquire Monster Digital, an electronic camera and data storage company.

Forest Laboratories and Allergan filed a suit against Sun Pharma for patent infringement in the District of Delaware’s U.S. District Court.

Takeda Pharmaceuticals President and CEO Christophe Weber could face increased scrutiny after the retirement of Chairman Yasuchika Hasegawa.

The FDA approved Salix Pharmaceuticals’ new drug application for Plenvu, a lower-volume polyethylene glycol-based bowel preparation developed for bowel cleansing.

Medial EarlySign entered into a strategic collaboration with Medicover for a pilot program aimed at identifying individuals with a high colorectal cancer risk.

More articles on gastroenterology:
Drs. Arnold Rosen, Akash Patel & more: 3 GI physicians making news
5 most read GI/endoscopy stories: June 26 — June 30, 2017
GI leader to know: Dr. Mark Marino of Metropolitan Gastroenterology Associates

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.